{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:48:33Z","timestamp":1774928913508,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s41687-019-0122-5","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T13:03:05Z","timestamp":1560776585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)"],"prefix":"10.1186","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-5233","authenticated-orcid":false,"given":"Tito R.","family":"Mendoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2788-657X","authenticated-orcid":false,"given":"Loretta A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen N.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Elbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna K.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffit","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Cuffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1460-6527","authenticated-orcid":false,"given":"Charles S.","family":"Cleeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"key":"122_CR1","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-15-2035","volume":"22","author":"PG Kluetz","year":"2016","unstructured":"Kluetz, P. G., Slagle, A., Papadopoulos, E. J., et al. (2016). Focusing on core patient-reported outcomes in cancer clinical trials: Symptomatic adverse events, physical function, and disease-related symptoms. Clin Cancer Res, 22, 1553\u20131558. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2035\n                    \n                  .","journal-title":"Clin Cancer Res"},{"issue":"12","key":"122_CR2","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1007\/s11136-018-1982-5","volume":"27","author":"Loretta A. Williams","year":"2018","unstructured":"Williams, L. A., Whisenant, M. S., Mendoza, T. R., et al. (2018). Modification of existing patient-reported outcome measures: Qualitative development of the MD Anderson symptom inventory for malignant pleural mesothelioma (MDASI-MPM). Qual Life Res:e-pub ahead of print. \n                    https:\/\/doi.org\/10.1007\/s11136-018-1982-5\n                    \n                  .","journal-title":"Quality of Life Research"},{"key":"122_CR3","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V","volume":"89","author":"CS Cleeland","year":"2000","unstructured":"Cleeland, C. S., Mendoza, T. R., Wang, X. S., et al. (2000). Assessing symptom distress in cancer patients: The M.D. Anderson symptom inventory. Cancer, 89, 1634\u20131646. \n                    https:\/\/doi.org\/10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V\n                    \n                  .","journal-title":"Cancer"},{"key":"122_CR4","unstructured":"US Food and Drug Administration. Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. 2009."},{"key":"122_CR5","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1007\/s00520-018-4061-0","volume":"26","author":"HL Gelhorn","year":"2018","unstructured":"Gelhorn, H. L., Skalicky, A. M., Balantac, Z., et al. (2018). Content validity and electronic PRO (ePRO) usability of the lung Cancer symptom scale-mesothelioma (LCSS-Meso) in mesothelioma patients. Support Care Cancer, 26, 2229\u20132238. \n                    https:\/\/doi.org\/10.1007\/s00520-018-4061-0\n                    \n                  .","journal-title":"Support Care Cancer"},{"key":"122_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00520-005-0837-0","volume":"14","author":"PJ Hollen","year":"2006","unstructured":"Hollen, P. J., Gralla, R. J., Liepa, A. M., Symanowski, J. T., & Rusthoven, J. J. (2006). Measuring quality of life in patients with pleural mesothelioma using a modified version of the lung Cancer symptom scale (LCSS): Psychometric properties of the LCSS-Meso. Support Care Cancer, 14, 11\u201321. \n                    https:\/\/doi.org\/10.1007\/s00520-005-0837-0\n                    \n                  .","journal-title":"Support Care Cancer"},{"key":"122_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken, M. M., Creech, R. H., Tormey, D. C., et al. (1982). Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol, 5, 649\u2013655.","journal-title":"Am J Clin Oncol"},{"key":"122_CR8","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1200\/JCO.2011.39.2381","volume":"30","author":"MJ Fisch","year":"2012","unstructured":"Fisch, M. J., Lee, J. W., Weiss, M., et al. (2012). Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol, 30, 1980\u20131988. \n                    https:\/\/doi.org\/10.1200\/JCO.2011.39.2381\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"122_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0304-3959(94)00178-H","volume":"61","author":"RC Serlin","year":"1995","unstructured":"Serlin, R. C., Mendoza, T. R., Nakamura, Y., Edwards, K. R., & Cleeland, C. S. (1995). When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain, 61, 277\u2013284. \n                    https:\/\/doi.org\/10.1016\/0304-3959(94)00178-H\n                    \n                  .","journal-title":"Pain"},{"key":"122_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pain.2004.10.024","volume":"113","author":"KO Anderson","year":"2005","unstructured":"Anderson, K. O. (2005). Role of cutpoints: Why grade pain intensity? Pain, 113, 5\u20136. \n                    https:\/\/doi.org\/10.1016\/j.pain.2004.10.024\n                    \n                  .","journal-title":"Pain"},{"key":"122_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jpain.2005.07.012","volume":"7","author":"GR Palos","year":"2006","unstructured":"Palos, G. R., Mendoza, T. R., Mobley, G. M., Cantor, S. B., & Cleeland, C. S. (2006). Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain, 7, 49\u201356. \n                    https:\/\/doi.org\/10.1016\/j.jpain.2005.07.012\n                    \n                  .","journal-title":"J Pain"},{"key":"122_CR12","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1002\/cncr.28376","volume":"119","author":"CS Cleeland","year":"2013","unstructured":"Cleeland, C. S., Zhao, F., Chang, V. T., et al. (2013). The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the eastern cooperative oncology group symptom outcomes and practice patterns study. Cancer, 119, 4333\u20134340. \n                    https:\/\/doi.org\/10.1002\/cncr.28376\n                    \n                  .","journal-title":"Cancer"},{"key":"122_CR13","volume-title":"Psychometric theory","author":"JC Nunnally","year":"1994","unstructured":"Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory (3rd ed.). New York: McGraw-Hill.","edition":"3"},{"key":"122_CR14","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/1097-0142(19940415)73:8<2087::AID-CNCR2820730813>3.0.CO;2-X","volume":"73","author":"PJ Hollen","year":"1994","unstructured":"Hollen, P. J., Gralla, R. J., Kris, M. G., et al. (1994). Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale. Cancer, 73, 2087\u20132098.","journal-title":"Cancer"},{"key":"122_CR15","unstructured":"Liepa AM, Hollen PJ, Gralla RJ, Rusthoven JJ (2001) Reliability and validity of modified lung Cancer symptom scale (LCSS) in multinational sample of patients with pleural mesothelioma [abstract]. International Society for Quality of life research (ISOQOL) 8th annual conference, Amsterdam, the Netherlands, Nov 7-10, 2001. Qual life res 10:280. Abstract #349."},{"key":"122_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen, J. (1992). A power primer. Psychol Bull, 112, 155\u2013159.","journal-title":"Psychol Bull"},{"key":"122_CR17","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: L. Erlbaum Associates.","edition":"2"},{"key":"122_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","volume":"61","author":"D Revicki","year":"2008","unstructured":"Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol, 61, 102\u2013109. \n                    https:\/\/doi.org\/10.1016\/j.jclinepi.2007.03.012\n                    \n                  .","journal-title":"J Clin Epidemiol"},{"key":"122_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11060-006-9135-z","volume":"80","author":"TS Armstrong","year":"2006","unstructured":"Armstrong, T. S., Mendoza, T., Gning, I., et al. (2006). Validation of the M.D. Anderson symptom inventory brain tumor module (MDASI-BT). J Neuro-Oncol, 80, 27\u201335. \n                    https:\/\/doi.org\/10.1007\/s11060-006-9135-z\n                    \n                  .","journal-title":"J Neuro-Oncol"},{"key":"122_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000178809","volume":"76","author":"I Gning","year":"2009","unstructured":"Gning, I., Trask, P. C., Mendoza, T. R., et al. (2009). Development and initial validation of the thyroid cancer module of the M. D Anderson Symptom Inventory Oncology, 76, 59\u201368. \n                    https:\/\/doi.org\/10.1159\/000178809\n                    \n                  .","journal-title":"D Anderson Symptom Inventory Oncology"},{"key":"122_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/hed.20602","volume":"29","author":"DI Rosenthal","year":"2007","unstructured":"Rosenthal, D. I., Mendoza, T. R., Chambers, M. S., et al. (2007). Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck, 29, 923\u2013931. \n                    https:\/\/doi.org\/10.1002\/hed.20602\n                    \n                  .","journal-title":"Head Neck"},{"key":"122_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cardfail.2008.01.012","volume":"14","author":"A Fadol","year":"2008","unstructured":"Fadol, A., Mendoza, T., Gning, I., et al. (2008). Psychometric testing of the MDASI-HF: A symptom assessment instrument for patients with cancer and concurrent heart failure. J Card Fail, 14, 497\u2013507. \n                    https:\/\/doi.org\/10.1016\/j.cardfail.2008.01.012\n                    \n                  .","journal-title":"J Card Fail"},{"key":"122_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s41687-018-0053-6","volume":"2","author":"S Safikhani","year":"2017","unstructured":"Safikhani, S., Gries, K. S., Trudeau, J. J., et al. (2017). Response scale selection in adult pain measures: Results from a literature review. J Patient Rep Outcomes, 2, 40. \n                    https:\/\/doi.org\/10.1186\/s41687-018-0053-6\n                    \n                  .","journal-title":"J Patient Rep Outcomes"},{"issue":"37","key":"122_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/jncimonographs\/lgm005","volume":"2007","author":"C. S. Cleeland","year":"2007","unstructured":"Cleeland, C. S. (2007). Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr, 16\u201321. \n                    https:\/\/doi.org\/10.1093\/jncimonographs\/lgm005\n                    \n                  .","journal-title":"JNCI Monographs"},{"issue":"5","key":"122_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85(5), 365\u2013376.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"122_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0959-8049(94)90535-5","volume":"30A","author":"B Bergman","year":"1994","unstructured":"Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: A modular supplement to the EORTC Core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC study group on quality of life. Eur J Cancer, 30A(5), 635\u2013642.","journal-title":"Eur J Cancer"},{"issue":"3","key":"122_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/cncr.20315","volume":"101","author":"PJ Hollen","year":"2004","unstructured":"Hollen, P. J., Gralla, R. J., Liepa, A. M., Symanowski, J. T., & Rusthoven, J. J. (2004). Adapting the lung Cancer symptom scale (LCSS) to mesothelioma: Using the LCSS-Meso conceptual model for validation. Cancer, 101(3), 587\u2013595.","journal-title":"Cancer"},{"issue":"15","key":"122_CR28","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1200\/JCO.2004.09.147","volume":"22","author":"AK Nowak","year":"2004","unstructured":"Nowak, A. K., Stockler, M. R., & Byrne, M. J. (2004). Assessing quality of life during chemotherapy for pleural mesothelioma: Feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core quality of life questionnaire and lung Cancer module. J Clin Oncol, 22(15), 3172\u20133180.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-019-0122-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41687-019-0122-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-019-0122-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T23:06:46Z","timestamp":1592262406000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-019-0122-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["122"],"URL":"https:\/\/doi.org\/10.1186\/s41687-019-0122-5","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]},"assertion":[{"value":"14 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients gave informed consent to participate in the Phase II clinical trial, which was approved by our Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The MD Anderson Symptom Inventory and its derivative versions are copyrighted and licensed by The University of Texas MD Anderson Cancer Center and Charles S. Cleeland. Xin Shelley Wang and Charles S. Cleeland have a financial interest in the MDASI and its derivative versions. The authors declare that they have no other competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"34"}}